BFRG vs. GDTC, NRSN, INDP, ONCT, BIOR, CPIX, ITRM, LSTA, ADXN, and DRRX
Should you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include CytoMed Therapeutics (GDTC), NeuroSense Therapeutics (NRSN), Indaptus Therapeutics (INDP), Oncternal Therapeutics (ONCT), Biora Therapeutics (BIOR), Cumberland Pharmaceuticals (CPIX), Iterum Therapeutics (ITRM), Lisata Therapeutics (LSTA), Addex Therapeutics (ADXN), and DURECT (DRRX). These companies are all part of the "pharmaceutical preparations" industry.
CytoMed Therapeutics (NASDAQ:GDTC) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk.
CytoMed Therapeutics has higher earnings, but lower revenue than Bullfrog AI.
CytoMed Therapeutics received 2 more outperform votes than Bullfrog AI when rated by MarketBeat users.
CytoMed Therapeutics currently has a consensus target price of $5.00, suggesting a potential upside of 132.56%. Given Bullfrog AI's higher possible upside, equities research analysts plainly believe CytoMed Therapeutics is more favorable than Bullfrog AI.
Bullfrog AI's return on equity of 0.00% beat CytoMed Therapeutics' return on equity.
In the previous week, Bullfrog AI's average media sentiment score of 0.00 equaled CytoMed Therapeutics'average media sentiment score.
0.0% of CytoMed Therapeutics shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
CytoMed Therapeutics beats Bullfrog AI on 6 of the 8 factors compared between the two stocks.
Get Bullfrog AI News Delivered to You Automatically
Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bullfrog AI Competitors List
Related Companies and Tools
